Literature DB >> 3902119

Changes in hematopoietic stem cells in bone marrow of mice with Plasmodium berghei malaria.

L Maggio-Price, D Brookoff, L Weiss.   

Abstract

An impaired erythropoietic response to anemia has been noted in human patients with malaria and in rodents experimentally infected with Plasmodium berghei. We have attempted to characterize the erythropoietic response in mice with a fatal P berghei infection, with particular emphasis on changes in marrow hematopoietic stem cells. Mice infected with P berghei had dramatic decreases in bone marrow cellularity, erythroblasts, BFU-E, and CFU-E as early as 24 hours postinfection and before there was any change in hematocrit. With development of anemia, marrows became erythropoietic with some expansion of the CFU-E compartment, but the BFU-E pool remained depleted and reticulocyte response was inadequate. There was no significant change in CFU-S from marrows of malaria-infected mice one day after infection. The lethality of malaria infection may take three weeks to be revealed, but it may be determined within hours of the infection by the irreparable changes in marrow erythroid stem cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902119

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Response of the murine hematopoietic system to chronic infection with Mycobacterium lepraemurium.

Authors:  M Resnick; E Fibach; M Lebastard; L Levy; H Bercovier
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

3.  Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.

Authors:  J A Martiney; B Sherry; C N Metz; M Espinoza; A S Ferrer; T Calandra; H E Broxmeyer; R Bucala
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Tumor necrosis factor alpha and the anemia associated with murine malaria.

Authors:  K L Miller; P H Silverman; B Kullgren; L J Mahlmann
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  Clinicopathologic features of young and old sphha/sphha mice. Mutants with congenital hemolytic anemia.

Authors:  L Maggio-Price; R Russell; N S Wolf; C E Alpers; D Engel
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

6.  Manipulating niche composition limits damage to haematopoietic stem cells during Plasmodium infection.

Authors:  Myriam L R Haltalli; Samuel Watcham; Nicola K Wilson; Kira Eilers; Alexander Lipien; Heather Ang; Flora Birch; Sara Gonzalez Anton; Chiara Pirillo; Nicola Ruivo; Maria L Vainieri; Constandina Pospori; Robert E Sinden; Tiago C Luis; Jean Langhorne; Ken R Duffy; Berthold Göttgens; Andrew M Blagborough; Cristina Lo Celso
Journal:  Nat Cell Biol       Date:  2020-11-23       Impact factor: 28.824

7.  Heme mediated STAT3 activation in severe malaria.

Authors:  Mingli Liu; Audu S Amodu; Sidney Pitts; John Patrickson; Jacqueline M Hibbert; Monica Battle; Solomon F Ofori-Acquah; Jonathan K Stiles
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.

Authors:  Michael A McDevitt; Jianlin Xie; Shanmugasundaram Ganapathy-Kanniappan; Ganapathy Shanmugasundaram; Jason Griffith; Aihua Liu; Courtney McDonald; Philip Thuma; Victor R Gordeuk; Christine N Metz; Robert Mitchell; Jeffrey Keefer; John David; Lin Leng; Richard Bucala
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

9.  Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors.

Authors:  Abigail A Lamikanra; Michel Theron; Taco W A Kooij; David J Roberts
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

Review 10.  Mesenchymal Stem Cells: A Novel Therapeutic Approach to Enhance Protective Immunomodulation and Erythropoietic Recovery in Malaria.

Authors:  Meenu Kalkal; Mrinalini Tiwari; Reva S Thakur; Vikky Awasthi; Veena Pande; Debprasad Chattopadhyay; Jyoti Das
Journal:  Stem Cell Rev Rep       Date:  2021-06-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.